Alimera Sciences Inc., of Atlanta, appointed Steven T. Gill vice president, thought leader engagement.
Biosig Technologies Inc., of Westport, Conn., appointed Jerome Zeldis executive chair of ViralClear Pharmaceuticals Inc., a new division within its majority-owned subsidiary Neuroclear Technologies Inc.
Brainstorm Cell Therapeutics Inc., of New York, appointed Jacob Frenkel chair of its board.
Cambrex Corp., of East Rutherford, N.J., appointed Troy Player president, early stage development and testing.
Cybrexa Therapeutics Inc., of New Haven, Conn., appointed Arthur DeCillis acting chief medical officer.
PCI Biotech AS, of Oslo, Norway, appointed Amir Snapir chief medical officer.
Redpin Therapeutics Inc., of New York, appointed Abhinav A. Shukla chief technical operations officer.
Sofinnova Investments, of Menlo Park, Calif., named Maha Katabi general partner and Sarah Bhagat partner.